decisionhealth Newsletters, Answer Books - 2009 Issue 3 (March)
Anti-Kickback Advisory Opinion Summaries / 2004 OIG Advisory Opinions / Opinion 04-03 - Doctors Can Get Dollars For Drug-Use Surveys
Subscribe or sign in to view the full article.
Article Overview
This summary reviews an OIG advisory opinion about whether small payments to physicians for completing product-related surveys raise anti-kickback concerns. It is relevant to compliance professionals, healthcare attorneys, physicians, and practice administrators who need a high-level understanding of how the OIG evaluates marketing-related survey arrangements and the safeguards discussed in the opinion.
Why This Topic Matters
Advisory opinions help stakeholders understand how federal fraud-and-abuse concerns may be analyzed in specific business arrangements. This article is useful for evaluating physician compensation tied to surveys, pharmaceutical marketing relationships, and compliance risk management.
What You Will Learn
- The general compliance issue addressed by the advisory opinion
- How physician survey payments are evaluated in a fraud-and-abuse context
- The types of safeguards described by the OIG
- Why survey design and referral influence matter in the opinion’s analysis
Who Should Read This
- Compliance officers
- Healthcare attorneys
- Physicians
- Practice administrators
- Medical group managers
- Pharmaceutical industry compliance teams
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com